Home/Filings/4/0001181431-12-011793
4//SEC Filing

Hebeda Dave 4

Accession 0001181431-12-011793

CIK 0001369786other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 7:55 PM ET

Size

5.3 KB

Accession

0001181431-12-011793

Insider Transaction Report

Form 4
Period: 2012-02-22
Hebeda Dave
Vice President, Finance
Transactions
  • Award

    Stock Option to Buy

    2012-02-22+4,3804,380 total
    Exercise: $22.04Exp: 2022-02-22Common Stock (4,380 underlying)
Footnotes (1)
  • [F1]The option vests in four equal annual installments beginning on February 22, 2013.

Documents

1 file

Issuer

Sagent Pharmaceuticals, Inc.

CIK 0001369786

Entity typeother

Related Parties

1
  • filerCIK 0001518009

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 7:55 PM ET
Size
5.3 KB